tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (SE:ACE)
:ACE
Sweden Market

Ascelia Pharma AB (ACE) Income Statement

Compare
1 Followers

Ascelia Pharma AB Income Statement

Last quarter (Q4 2024), Ascelia Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Ascelia Pharma AB's net income was kr-28.33M. See Ascelia Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr -1.05Mkr -3.89Mkr -8.72Mkr -825.00K
Operating Expenses
kr 67.77Mkr 110.91Mkr 143.78Mkr 129.17Mkr 93.26M
Depreciation and Amortization
kr 74.00Kkr 1.05Mkr 1.05Mkr 1.03Mkr 825.00K
EBITDA
kr -67.69Mkr -108.56Mkr -132.06Mkr -128.42Mkr -98.91M
Operating Income
kr -67.77Mkr -110.91Mkr -147.01Mkr -137.95Mkr -93.43M
Other Income/Expenses
kr -12.36Mkr 1.31Mkr 13.85Mkr 8.43Mkr -6.32M
Pretax Income
kr -80.12Mkr -109.61Mkr -133.16Mkr -129.52Mkr -99.75M
Net Income
kr -80.03Mkr -109.29Mkr -131.22Mkr -125.90Mkr -98.70M
Per Share Metrics
Basic EPS
kr -1.48kr -3.24kr -3.77kr -3.82kr -3.76
Diluted EPS
kr -1.48kr -3.24kr -3.90kr -3.82kr -3.76
Weighted Average Shares Outstanding
54.00M 33.72M 33.67M 32.96M 26.27M
Weighted Average Shares Outstanding (Diluted)
54.00M 33.72M 34.80M 32.96M 26.27M
Currency in SEK

Ascelia Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis